ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,521.52
-1.39%
US Tech 100
18,837.60
-1.25%
Dow Jones
40,813.57
-1.30%
Brent Oil
70.07
0.21%
Bitcoin
82,029.68
1.22%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Prothena Corporation PLC (PRTA)

  7. Prothena Corporation PLC (PRTA) News

PRTA

Prothena (PRTA)

Prothena Corporation PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTA
DateTimeSourceHeadlineSymbolCompany
03/07/20254:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
03/07/20254:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
03/07/20254:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
03/07/20254:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
03/07/20254:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
03/07/20254:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
02/27/20255:05PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PRTAProthena Corporation PLC
02/20/20254:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
02/20/20254:05PMBusiness WireProthena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
02/14/20253:35PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PRTAProthena Corporation PLC
02/13/20254:05PMBusiness WireProthena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025NASDAQ:PRTAProthena Corporation PLC
01/03/20257:45PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:PRTAProthena Corporation PLC
12/30/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
12/30/20244:05PMBusiness WireProthena Announces Board of Directors UpdateNASDAQ:PRTAProthena Corporation PLC
12/19/20241:05AMBusiness WireRoche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s DiseaseNASDAQ:PRTAProthena Corporation PLC
11/13/20247:00AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PRTAProthena Corporation PLC
11/12/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
11/12/20244:05PMBusiness WireProthena Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
11/05/20244:05PMBusiness WireProthena to Report Third Quarter 2024 Financial Results on November 12NASDAQ:PRTAProthena Corporation PLC
10/03/20246:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
10/03/20246:57PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
09/27/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
09/27/20244:05PMBusiness WireProthena Announces Leadership Team UpdatesNASDAQ:PRTAProthena Corporation PLC
08/29/20244:05PMBusiness WireProthena to Participate in Upcoming Healthcare ConferencesNASDAQ:PRTAProthena Corporation PLC
08/08/20245:13PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTAProthena Corporation PLC
08/08/20244:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRTAProthena Corporation PLC
08/08/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
08/08/20244:05PMBusiness WireProthena Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
08/01/20244:05PMBusiness WireProthena to Report Second Quarter 2024 Financial Results on August 8NASDAQ:PRTAProthena Corporation PLC
05/28/20244:05PMBusiness WireProthena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development CollaborationNASDAQ:PRTAProthena Corporation PLC
 Showing the most relevant articles for your search:NASDAQ:PRTA

Your Recent History

NASDAQ
FPXI
First Trust Internationa...
BIT
Q00349
Leonteq Securities
TG
35U
Par Technology
LSE
19UR
Sg Issuer 30
BIT
UV4KSS
Unicredit
LSE
EMHD
Inv Ft Em Hdlv
LSE
AS70
Bank Mont.25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads